These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2345835)

  • 1. The applicability of results of streamlined trials to clinical practice: the Myocarditis Treatment Trial.
    O'Connell JB; Mason JW
    Stat Med; 1990; 9(1-2):193-6; discussion 196-7. PubMed ID: 2345835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The applicability of the results of streamlined trials to clinical practice.
    Wilhelmsen L
    Stat Med; 1990; 9(1-2):185-91. PubMed ID: 2345834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trials in heart failure: can we expect the results to be replicated in clinical practice?
    Massie BM
    J Card Fail; 1998 Sep; 4(3):243-7. PubMed ID: 9754598
    [No Abstract]   [Full Text] [Related]  

  • 4. Trends in the use of pharmacotherapies for acute myocardial infarction among physicians who design and/or implement randomized trials versus physicians in routine clinical practice: the MILIS-TIMI experience. Multicenter Investigation on Limitation of Infarct Size. Thrombolysis in Myocardial Infarction.
    Kizer JR; Cannon CP; McCabe CH; Mueller HS; Schweiger MJ; Davis VG; Perritt R; Antman EM
    Am Heart J; 1999 Jan; 137(1):79-92. PubMed ID: 9878939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of inflammatory dilated cardiomyopathy and (peri)myocarditis with immunosuppression and i.v. immunoglobulins.
    Maisch B; Hufnagel G; Kölsch S; Funck R; Richter A; Rupp H; Herzum M; Pankuweit S
    Herz; 2004 Sep; 29(6):624-36. PubMed ID: 15912438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are We Too Quick to Alter Our Practice Patterns Because of the Results of a Randomized Controlled Trial?
    Jupiter J
    Tech Hand Up Extrem Surg; 2018 Mar; 22(1):1-2. PubMed ID: 29369124
    [No Abstract]   [Full Text] [Related]  

  • 7. External validity: we need to do more.
    Glasgow RE; Green LW; Klesges LM; Abrams DB; Fisher EB; Goldstein MG; Hayman LL; Ockene JK; Orleans CT
    Ann Behav Med; 2006 Apr; 31(2):105-8. PubMed ID: 16542124
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical Epidemiology Workshop 8--appraising a study on therapy.
    Yu IT; Tse SL
    Hong Kong Med J; 2012 Oct; 18(5):419-20. PubMed ID: 23018070
    [No Abstract]   [Full Text] [Related]  

  • 9. The Myocarditis Treatment Trial: design, methods and patients enrollment.
    Hahn EA; Hartz VL; Moon TE; O'Connell JB; Herskowitz A; McManus BM; Mason JW
    Eur Heart J; 1995 Dec; 16 Suppl O():162-7. PubMed ID: 8682088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of cluster-randomized trials of quality improvement interventions aimed at medical care providers.
    Glynn RJ; Brookhart MA; Stedman M; Avorn J; Solomon DH
    Med Care; 2007 Oct; 45(10 Supl 2):S38-43. PubMed ID: 17909381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory cardiomyopathy (myocarditis): which patients should be treated with anti-inflammatory therapy?
    Parrillo JE
    Circulation; 2001 Jul; 104(1):4-6. PubMed ID: 11435327
    [No Abstract]   [Full Text] [Related]  

  • 12. A clinic's perspective on screening, recruitment and data collection.
    Eaton T; Pratt CM
    Stat Med; 1990; 9(1-2):137-43; discussion 143-4. PubMed ID: 2189188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of disopyramide by arrhythmia specialists after Cardiac Arrhythmia Suppression Trial: patient selection and initial outcome.
    Prystowsky EN; Waldo AL; Fisher JD
    Am Heart J; 1991 May; 121(5):1571-82. PubMed ID: 2017999
    [No Abstract]   [Full Text] [Related]  

  • 14. Patients enrolled in large randomized clinical trials of antiplatelet treatment for prevention after transient ischemic attack or ischemic stroke are not representative of patients in clinical practice: the Netherlands Stroke Survey.
    Maasland L; van Oostenbrugge RJ; Franke CF; Scholte Op Reimer WJ; Koudstaal PJ; Dippel DW;
    Stroke; 2009 Aug; 40(8):2662-8. PubMed ID: 19556533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physicians' preferences for active-controlled versus placebo-controlled trials of new antihypertensive drugs.
    Halpern SD; Ubel PA; Berlin JA; Townsend RR; Asch DA
    J Gen Intern Med; 2002 Sep; 17(9):689-95. PubMed ID: 12220365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct-to-consumer advertising and physician prescribing.
    Miller FG; Wendler D
    JAMA; 2005 Aug; 294(6):678; author reply 678-9. PubMed ID: 16091566
    [No Abstract]   [Full Text] [Related]  

  • 17. Can antibiotic prescriptions in respiratory tract infections be improved? A cluster-randomized educational intervention in general practice--the Prescription Peer Academic Detailing (Rx-PAD) Study [NCT00272155].
    Gjelstad S; Fetveit A; Straand J; Dalen I; Rognstad S; Lindbaek M
    BMC Health Serv Res; 2006 Jun; 6():75. PubMed ID: 16776824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled trials 1: Design.
    Curtis BM; Barrett BJ; Parfrey PS
    Methods Mol Biol; 2015; 1281():159-75. PubMed ID: 25694309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncologist's role critical to clinical trial enrollment.
    Finn R
    J Natl Cancer Inst; 2000 Oct; 92(20):1632-4. PubMed ID: 11036104
    [No Abstract]   [Full Text] [Related]  

  • 20. A cluster-randomized educational intervention to reduce inappropriate prescription patterns for elderly patients in general practice--The Prescription Peer Academic Detailing (Rx-PAD) study [NCT00281450].
    Straand J; Fetveit A; Rognstad S; Gjelstad S; Brekke M; Dalen I
    BMC Health Serv Res; 2006 Jun; 6():72. PubMed ID: 16764734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.